For example, GPX4 expression is reported to be upregulated in hepatocellular carcinoma and colorectal cancer [18, 19], and high GPX4 expression is associated with poor prognosis in gastric cancer [9] and lung adenocarcinoma [10]. This evidence concerns the gene GPX4 and colorectal cancer.